Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Diseases × abiraterone × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 16 Neoplasm Metastasis 3 Prostatic Neoplasms, Castration-Resistant 2 Bulbo-Spinal Atrophy, X-Linked 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostate Cancer Metastatic Disease 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Melanoma 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bites and Stings 1 Anus Neoplasms 1 Advanced Solid Tumor 1 Adenocarcinoma 1

Interventions

darolutamide 2 olaparib 1 gedatolisib 1 Radiotherapy 1 Pluvicto 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Brachytherapy 1 Androgen Antagonists 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡